Spots Global Cancer Trial Database for Tracer-Guided Surgery for Recurrent Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Tracer-Guided Surgery for Recurrent Prostate Cancer

Official Title: Tracer-Based Image Guided Surgery for Recurrent Prostate Cancer: A Prospective Randomized Controlled Trial

Study ID: NCT05555017

Conditions

Prostate Cancer

Interventions

PSMA-radioguided surgery

ADT

Study Description

Brief Summary: ADT with or without robot-assisted PSMA-radioguided surgery for patients with recurrent prostate cancer.

Detailed Description: Improving the oncological treatment outcomes in men with a biochemical recurrence after primary prostate cancer (PC) treatment that are diagnosed with a disease recurrence confined to the regional lymph nodes or local residual disease using Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography and Computed Tomography (PET/CT.) The proposed trial randomizes patients with recurrent PC following primary PC treatment to either 6 months of ADT or Technetium-PSMA-radioguided salvage surgery plus 6 months of ADT. Although the optimal duration of ADT is unknown, a minimal duration of 6 months of ADT seems advisable in this setting and will be mandatory for both arms.